Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent- mediated central mechanisms

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 273, Issue 4 36-4, 1997, Pages

  Imeryüz, Neşe ^a   Yeǧen, Berrak Ç ^a   Bozkurt, Ayhan ^a   Coşkun, Tamer ^a   Villanueva Penacarrillo, Maria L ^b   Ulusoy, Nefise B ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Acid secretion; Exendin; Feeding behavior; Glucose

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ANIMAL EXPERIMENT; ARTICLE; DENERVATION; FEEDING BEHAVIOR; FEMALE; GLUCOSE INTAKE; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; STOMACH EMPTYING; VAGUS NERVE STIMULATION;

EID: 0030853076     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1997.273.4.g920     Document Type: Article

References (21)

1. Anvari, M., C. A. Paterson, E. E. Daniel, and T. J. McDonald. Effect of GLP-1 on antropyloric motility, transpyloric flow and gastric emptying of non-nutrient liquids in conscious dogs (Abstract). Gastroenterology 108: A501, 1995.
2. Drucker, D. J., and S. Asa. Glucagon gene expression in vertebrate brain. J. Biol. Chem. 263: 13475-13478, 1988.
3. Eng, J., W. A. Kleinman, L. Singh, G. Singh, and J. P. Raufman. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J. Biol. Chem. 267: 7402-7405, 1992.
4. Fehmann, H. C., and J. F. Habener, Insulinotropic glucagon-like peptide 1 (7-31)/(1-36) amide: a new incretin hormone Trends Endocrinol. Metab. 3: 158-163, 1992.
5. Göke, R., P. J. Larsen, J. D. Mikkelsen, and S. P. Sheikh. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur. J. Neurosci. 7: 2294-2300, 1995.
6. Göke, R., H. C. Fehmann, T. Linn, H. Schmidt, M. Krause, J. Eng, and B. Göke. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like-peptide 1-(7-36)-amide receptor of insulin secreting β-cells. J. Biol. Chem. 268: 19650-19655, 1993.
7. Green, T., R. Dimaline, S. Peikin, and G. J. Dockray. The action of the cholecystokinin antagonist L-364,718 on gastric emptying in the rat. Am. J. Physiol. 255 (Gastrointest. Liver Physiol. 18): G685-G689, 1988.
8. Gutniak, M., C. Ørskov, J. J. Holst, B. Ahren, and S. Efendic. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 326: 1316-1322, 1992.
9. Han, V. K. M., M. A. Hynes, C. Jin, A. C. To wie, J. M. Lauder, and P. K. Lund. Cellular localization of proglucagon/glucagon-like peptide 1 messenger RNAs in rat brain. J. Neurosci. Res. 16: 97-107, 1986.
10. Hendrick, G. K., A. Gjinovci, L. A. Baxter, S. Mojsov, C. B. Wollheim, J. F. Habener, and G. C. Weir. Glucagon-like peptide-1 (7-37) suppresses hyperglycemia in rats. Metabolism 42: 1-6, 1993.
11. Jia, X., J. C. Brown, Y. N. Kwok, H.A. Pederson, and C. H. S. McIntosh. Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach. Can. J. Physiol. Pharmacol. 72: 1215-1219, 1994.
12. Johnson, A. K., and P. M. Gross. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 7: 678-686, 1993.
13. Kolligs, F., H. C. Fehmann, R. Göke, and B. Göke. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 44: 16-19, 1995.
14. Nauck, M. A., U. Niedereichholz, R. Ettler, C. Ørskov, J. J. Holst, and W. Schmiegel. Evidence against a physiological role of GLP-1 as an insulinotropic incretin hormone in healthy volunteers (Abstract). Gastroenterology 110: A233, 1996.
15. 2: a physiological inhibitor of gastric acid secretion in man. J. Endocrinol. 126: 169-173, 1990.
16. Ørskov, C., J. Jeppesen, S. Madsbad, and J. J. Holst. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J. Clin. Invest. 87: 415-423, 1991.
17. Ørskov, C., S. S. Poulsen, M. Moller, and J. J. Holst. Glucagon-like peptide 1 receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide 1. Diabetes 45: 832-835, 1996.
18. 17a.Paxinos, G., and C. Watson. The Rat Brain in Stereotaxic Coordinates. New York: Academic, 1986.
19. Raybould, H. E., C. Sternini, V. E. Eysselein, M. Yonedo, and P. Holzer. Selective ablation of spinal afferent neurons containing CGRP attenuates gastric hyperemic response to acid. Peptides 13: 243-256, 1992.
20. Raybould, H. E., T. T. Zittel, H. H. Holzer, K. C. K. Lloyd, and J. H. Meyer. Gastroduodenal sensory mechanisms and CCK in inhibition of gastric emptying in response to a meal. Dig. Dis. Sci. 39, Suppl.: 41S-43S, 1994.
21. Rogers, R. C., D. M. McTigue, and G. E. Hermann. Vagal control of digestion: modulation by central neural and peripheral endocrine factors. Neurosci. Biobehav. Rev. 20: 57-66, 1996.